MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). (Q38325925)

2 September 2017

title

MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). (English)

1 reference

malignant peripheral nerve sheath tumor

2 September 2017

main subject

0 references

microRNA

1 reference

adult malignant schwannoma

inferred from title

1 reference

1 reference

Satoru Itani

1

1 reference

2 September 2017

Toshiyuki Kunisada

2

1 reference

2 September 2017

Yuki Morimoto

3

1 reference

2 September 2017

Aki Yoshida

4

1 reference

2 September 2017

Tsuyoshi Sasaki

5

1 reference

2 September 2017

Sachio Ito

6

1 reference

2 September 2017

Mamoru Ouchida

7

1 reference

2 September 2017

Shinsuke Sugihara

8

1 reference

2 September 2017

Kenji Shimizu

9

1 reference

2 September 2017

Toshifumi Ozaki

10

1 reference

2 September 2017

publication date

22 April 2012

1 reference

Journal of Cancer Research and Clinical Oncology

2 September 2017

published in

1 reference

2 September 2017

volume

138

1 reference

2 September 2017

issue

9

1 reference

2 September 2017

page(s)

1501-1509

1 reference

Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Pdcd4, a colon cancer prognostic that is regulated by a microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

miR-21: an oncomir on strike in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

MicroRNomics: a newly emerging approach for disease biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1223-1

Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors.

21 January 2018

1 reference

12 December 2020

MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival

1 reference

12 December 2020

Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo

1 reference

12 December 2020

A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation

1 reference

12 December 2020

Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.

1 reference

12 December 2020

TM4: a free, open-source system for microarray data management and analysis

1 reference

12 December 2020

Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients

1 reference

12 December 2020

Germline and somatic NF1 gene mutations in plexiform neurofibromas

1 reference

12 December 2020

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

12 December 2020

Establishment of an epithelioid malignant schwannoma cell line (YST-1).

1 reference

12 December 2020

Germline mutations in NF1 patients with malignancies

1 reference

12 December 2020

MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

1 reference

12 December 2020

Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.

1 reference

12 December 2020

10.1007/S00432-012-1223-1

Identifiers

DOI

1 reference

2 September 2017

1 reference